Welcome Guest
Sign In
Register
Research & Development
Quality
Regulatory
Manufacturing
Home
News
Articles
MAGAZINE
Resources
Sponsored Q&A
Whitepapers
eBooks
Infographics
Videos
Webinars
Products
Featured Products
New Products
Company Profiles
Events
FAQ
David Tanzer, MD
David Tanzer, MD
Chief Medical Officer
Lexitas
David is an ophthalmologist and chief medical officer at Lexitas Pharma Services. He previously served in roles with the U.S. Navy, academia, private practice and industry, from the medical device and biotechnology arenas to strategic pharmaceutical companies. With expertise spanning R&D, medical affairs, safety, commercialization, compliance and quality assurance and a reputation for creating lasting organizational value, Dr. Tanzer has led initiatives supporting product growth, patient safety and global medical affairs excellence.
Articles by David Tanzer, MD
Ten best practices for developing ophthalmic CGTs
Wednesday, May 20, 2026
Here are 10 best practices that can help drug developers avoid delays, protect data quality, and meet regulatory, clinical and manufacturing expectations.
Subscribe to eNewsletters
Keep up with latest in cell and gene therapy news and events, delivered straight to your inbox.
Subscribe to Magazine
Apr/May/Jun 2026 edition now available!
Get started here for your complimentary print or digital subscription
Sign up Now »
Upcoming Events
AAPS Summer Scientific Forum 2026
July 13-16, 2026
5th Process Development for Cell ...
July 14-16, 2026
5th In Vivo Cell Engineering & Gene ...
July 28-30, 2026
Connect with Us